These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1830454)

  • 1. Fibrinogen date: congenital hypodysfibrinogenemia associated with decreased binding of tissue-plasminogen activator.
    Ieko M; Sawada K; Sakurama S; Yamagishi I; Isogawa S; Nakagawa S; Satoh M; Yasukouchi T; Matsuda M
    Am J Hematol; 1991 Aug; 37(4):228-33. PubMed ID: 1830454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys).
    Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A
    Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum.
    Schorer AE; Singh J; Basara ML
    Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
    Krause WH; Huth K; Heene DL; Lasch HG
    Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of residues in the fibrin(ogen) gamma chain involved in tissue plasminogen activator binding and plasminogen activation.
    Wilhelm SE; Lounes KC; Lord ST
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):451-61. PubMed ID: 15311153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML
    Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
    Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary dysfibrinogenemia in a patient with thrombotic disease.
    Carrell N; Gabriel DA; Blatt PM; Carr ME; McDonagh J
    Blood; 1983 Aug; 62(2):439-47. PubMed ID: 6191801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.
    Niwa K; Takebe M; Sugo T; Kawata Y; Mimuro J; Asakura S; Sakata Y; Mizushima J; Maeda A; Endo H; Matsuda M
    Blood; 1996 Jun; 87(11):4686-94. PubMed ID: 8639838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
    Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
    Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Marseille. A new case of congenital dysfibrinogenaemia.
    Soria J; Soria C; Juhan I; Perrimond H; Haverkate F; Orsini A
    Haemostasis; 1980; 9(4):214-25. PubMed ID: 7399353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.